Literature DB >> 92553

Unusual features in a case diagnosed as subacute sclerosing panencephalitis (SSPE).

K A Flügel, A Barocka, H Woelk.   

Abstract

SSPE is characterised by progressive mental deterioration, myoclonic and similar motor disorders and final severe comatose states, increase of immunoglobuline G in the CSF, strongly elevated antibody titers to measles virus in serum and CSF and typical periodic K-complexes in the EEG. The disease appears commonly in childhood and has a fatal course. Cases with atypical signs have occasionally been reported. The case described in this paper shows a number of uncommon features: late onset, partial remission and stationary course, increased antibody titers to measles virus but relatively low in comparison to others, dissociation of cytoplasmic and nuclear fluorescent antibodies against SSPE brain tissue and an initial increase of antibodies against rubella virus. The patient was treated with isoprinosine. Improvement was observed before the start of this therapy and stabilized while treatment was being continued.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92553     DOI: 10.1007/bf00314644

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  SUBACUTE SCLEROSING (INCLUSION BODY) ENCEPHALITIS.

Authors:  N S CLARK; P V BEST
Journal:  Arch Dis Child       Date:  1964-08       Impact factor: 3.791

2.  Additional evidence of the relation between subacute inclusion-body encephalitis and measles virus.

Authors:  J M Freeman; R L Magoffin; E H Lennette; R M Herndon
Journal:  Lancet       Date:  1967-07-15       Impact factor: 79.321

3.  Subacute sclerosing panencephalitis and Salk vaccine.

Authors:  D M Baguley; G L Glasgow
Journal:  Lancet       Date:  1973-10-06       Impact factor: 79.321

4.  Subacute sclerosing panencephalitis. Spontaneous improvement in a patient with elevated measles antibody in blood and spinal fluid.

Authors:  J S Resnick; W K Engel; J L Sever
Journal:  N Engl J Med       Date:  1968-07-18       Impact factor: 91.245

5.  Non-fatal subacute sclerosing leucoencephalitis.

Authors:  W A Cobb; J A Morgan-Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-04       Impact factor: 10.154

6.  A ten-year experience with subacute sclerosing panencephalitis.

Authors:  C Kennedy
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

7.  Substantial spontaneous long-term improvement in subacute sclerosing panencephalitis. Six cases from the Middle East and a review of the literature.

Authors:  W S Risk; F S Haddad; R Chemali
Journal:  Arch Neurol       Date:  1978-08

8.  [An atypical case of subacute sclerosing leukoencephalitis (van Bogaert)].

Authors:  P Schubert
Journal:  Acta Neuropathol       Date:  1966-01-14       Impact factor: 17.088

9.  [Pathogenetic and therapeutic aspects of subacute sclerosing encephalitis (author's transl)].

Authors:  H Glasner; W Kirsch
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1975-12-23

10.  Progressive rubella panencephalitis. Late onset after congenital rubella.

Authors:  J J Townsend; J R Baringer; J S Wolinsky; N Malamud; J P Mednick; H S Panitch; R A Scott; L Oshiro; N E Cremer
Journal:  N Engl J Med       Date:  1975-05-08       Impact factor: 91.245

View more
  1 in total

Review 1.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.